Table 1 Baseline clinical characteristics

From: Predictors of the effects of smoking cessation on the endothelial function of conduit and digital vessels

Variables

Abstainers (n = 58)

Continued smokers (n = 21)

p value

Age (years)

64 ± 11

61 ± 8

0.076

Female, n (%)

18 (31.0)

3 (14.3)

0.137

Brinkman index

785 ± 439

669 ± 258

0.417

CO (ppm)

10.4 ± 7.8

11.8 ± 7.0

0.354

BMI (kg/m2)

23.6 ± 4.0

24.0 ± 2.8

0.728

Waist circumference (cm)

85.8 ± 11.0

87.3 ± 8.6

0.577

Hypertension, n (%)

26 (44.8)

11 (52.4)

0.522

SBP (mmHg)

118.6 ± 20.7

127.0 ± 18.1

0.063

DBP (mmHg)

74.4 ± 11.0

81.1 ± 7.7

0.012

HR (beats/min)

66.8 ± 11.6

67.0 ± 9.1

0.667

Diabetes mellitus, n (%)

7 (12.1)

5 (23.8)

0.153

Fasting glucose (mg/dl)

96.0 ± 13.4

102.4 ± 19.4

0.099

HbA1c (%)

5.8 ± 0.4

5.9 ± 0.8

0.815

HOMA-R

1.73 ± 1.33

1.83 ± 1.32

0.852

Dyslipidemia, n (%)

43 (74.1)

14 (66.7)

0.513

Total cholesterol (mg/dl)

190.7 ± 37.7

186.9 ± 31.5

0.695

HDL-C (mg/dl)

51.9 ± 18.2

51.5 ± 16.7

0.809

LDL-C (mg/dl)

108.7 ± 36.6

109.8 ± 25.6

0.899

Triglycerides (mg/dl)

161.0 ± 132.0

128.2 ± 45.7

0.109

Creatinine (mg/dl)

0.81 ± 0.24

0.80 ± 0.15

0.982

Uric acid (mg/dl)

6.1 ± 1.6

6.6 ± 1.8

0.286

CRP (mg/dl)

0.15 ± 0.19

0.20 ± 0.36

0.976

Baseline diameter (mm)

4.10 ± 0.68

4.35 ± 0.55

0.137

Blood flow increase (%)

338 ± 172

317 ± 204

0.253

FMD (%)

3.80 ± 2.24

4.41 ± 2.01

0.235

baIMT (mm)

0.31 ± 0.07

0.31 ± 0.06

0.911

RHI

1.88 ± 0.54

1.69 ± 0.29

0.424

Ln-RHI

0.59 ± 0.28

0.51 ± 0.17

0.167

CAVI

8.86 ± 1.45

8.56 ± 1.13

0.436

Previous CAD, n (%)

7 (12.1)

2 (9.5)

0.554

Medication, n (%)

 Antihypertensive

22 (37.9)

9 (42.9)

0.692

 Oral hypoglycemic

7 (12.1)

4 (19.0)

0.324

 Lipid lowering

21 (36.2)

7 (33.3)

0.814

Pharmacotherapy, n (%)

 Varenicline

38 (65.5)

9 (42.6)

0.070

 Nicotine patch

12 (20.7)

6 (28.6)

0.325

  1. CO carbon monoxide, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, HbA1c glycosylated hemoglobin, HOMA-R homeostasis model assessment of insulin resistance, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, CRP C-reactive protein, baseline diameter baseline brachial artery diameter, baIMT brachial artery intima-media thickness, FMD flow-mediated dilation, RHI reactive hyperemia index, Ln-RHI a natural logarithmic transformation of RHI, CAVI cardio-ankle vascular index, CAD coronary artery disease
Back to article page